65th Annual Meeting of the German Society of Neurosurgery (DGNC)
German Society of Neurosurgery (DGNC)
11 - 14 May 2014, Dresden
Lectures Tuesday, May 13 2014
DI.16 Brain Tumors – Laboratory Investigations 2
Meeting Abstract
(DI.16.01)
[Full Text]
Morphological, phenotypical and possibly functional heterogeneity of glioma stem cell compartment
Renovanz M, Kalasauskas D, Sprang B, Janocha M, Schulz-Schaeffer W, Giese A, Kim EL[Full Text]
Meeting Abstract
(DI.16.02)
[Full Text]
Endogenous neural precursor cells accumulate at tumors of the human brain and induce cell death of high-grade gliomas
Glass R, Stock K, Macas J, Kettenmann H, Momma S, Synowitz M[Full Text]
Meeting Abstract
(DI.16.03)
[Full Text]
Different mechanisms of tumor growth reduction by blockade of IGF-1R in U87-induced and stem-like cell-induced glioblastoma
Zamykal M, Martens T, Westphal M, Lamszus K[Full Text]
Meeting Abstract
(DI.16.04)
[Full Text]
Expression of pluripotency stemness genes in human gliomas of different tumor grades before and after chemotherapy
Dreher L, Röhn G, Perrech M, Goldbrunner R, Timmer M[Full Text]
Meeting Abstract
(DI.16.05)
[Full Text]
Microglia/macrophages with pro-angiogenic properties in glioblastoma
Brandenburg S, Müller A, Turkowski K, Radev Y, Heppner FL, Vajkoczy P[Full Text]
Meeting Abstract
(DI.16.06)
[Full Text]
Glioma-initiating cell-induced Interleukin-6 production is mediated by Toll-like receptor 4 in microglia
Dildar a Dzaye O, Hu F, Derkow K, Euskirchen P, Harms C, Lehnardt S, Wolf SA, Kettenmann H, Synowitz M[Full Text]
Meeting Abstract
(DI.16.07)
[Full Text]
The strong antiproliferative effects of FTY720 (fingolimod) in glioblastoma cells in vitro
Kolodziej M, Al-Barim B, Stein M, Reinges M, Uhle F, Quint K, Uhl E[Full Text]
Meeting Abstract
(DI.16.08)
[Full Text]
Immunological markers in long-term survivors with glioblastoma multiforme
Zett AB, Mawrin C, Schneider T[Full Text]
Meeting Abstract
(DI.16.09)
[Full Text]
KPNA2 predicts long-term survival in patients with anaplastic oligoastrocytomas
Gousias K, Niehusmann P, Gielen GH, Simon M, Boström J[Full Text]
Meeting Abstract
(DI.16.10)
[Full Text]
Identification of metabolomic phenotypes of malignancy in IDH-mutant gliomas
Loebel F, Cheng LL, Decelle EA, Chi AS, Andronesi OC, Cahill DP[Full Text]
Meeting Abstract
(DI.16.11)
[Full Text]
Monitoring of treatment response in IDH-mutant gliomas by assessment of 2-hydroxyglutarate with in-vivo magnetic resonance spectroscopy
Loebel F, Bogner W, Gerstner ER, Rosen BR, Chi AS, Cahill DP, Andronesi OC[Full Text]
Meeting Abstract
(DI.16.12)
[Full Text]
EGFR-associated intratumoral heterogeneity – impact on tumor initiation, progression and response to targeted therapy deciphered by multicolor labeling of EGFR-amplified glioblastoma cells
Liffers K, Riecken K, Fehse B, Westphal M, Lamszus K, Schulte A[Full Text]
